Ceribell (CBLL) Debt to Equity (2024 - 2026)
Ceribell (CBLL) reported Debt to Equity of $0.14 for Q1 2026, up 30.41% on a YoY basis from $0.11 in Q1 2025, and up 10.9% quarter-over-quarter from $0.13 in Q4 2025.
Ceribell (CBLL) Debt to Equity (2024 - 2026) Analysis & Trends
Ceribell has reported Debt to Equity for 3 years, with the latest figure at $0.14 in Q1 2026.
- For the quarter ending Q1 2026, Debt to Equity rose 30.41% year-over-year to $0.14; the trailing twelve-month figure through Mar 2026 stood at $0.14 (up 30.41% YoY), and the FY2025 full-year result was $0.13, up 24.66% from the prior year.
- Debt to Equity for Q1 2026 stood at $0.14, up from $0.13 in the prior quarter.
- The five-year high for Debt to Equity was $0.14 in Q1 2026, with the low at -$0.14 in Q3 2024.
- Historically, Debt to Equity has averaged $0.08 across 3 years, with a median of $0.11 in 2025.
- The largest YoY upside for Debt to Equity was 183.93% in 2025 against a maximum downside of 24.66% in 2025.
- Ceribell's Debt to Equity stood at $0.1 in 2024, then gained by 24.66% to $0.13 in 2025, then climbed by 10.9% to $0.14 in 2026.
- The last three Debt to Equity figures came in at $0.14 (Q1 2026), $0.13 (Q4 2025), and $0.12 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 0.65 |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 0.64 |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 0.57 |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 0.42 |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 0.06 |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 0.95 |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.71 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 0.27 |
| 10 | Ceribell | 695.83 Mn | 554.65 Mn | 23.12 Mn | 0.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.14 |
| Dec 31, 2025 | 0.13 |
| Sep 30, 2025 | 0.12 |
| Jun 30, 2025 | 0.11 |
| Mar 31, 2025 | 0.11 |
| Dec 31, 2024 | 0.10 |
| Sep 30, 2024 | -0.14 |